American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revision. Washington, DC: American Psychiatric Association; 2000.
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization; 1992.
Conradi, HJ, Ormel, J, de Jonge, P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med. 2011; 41(6): 1165–1174.
Baune, BT, Miller, R, McAfoose, J, etal. The role of cognitive impairment in general functioning in major depression. Psychiatry Res. 2010; 176(2–3): 183–189.
Pedrelli, P, Baer, L, Losifescu, DV, Fava, M. Relationship between residual symptoms of depression and self-reported cognitive impairment. CNS Spectr. 2010; 15(1): 46–51.
Fava, M, Graves, LM, Banazzi, F, etal. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. J Clin Psychiatry. 2006; 67(11): 1754–1759.
McClintock, SM, Husain, MM, Wisniewski, SR, etal. Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. J Clin Psychopharmacol. 2011; 31(2): 180–186.
Judd, LL, Akiskal, HS, Maser, JD, etal. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord. 1998; 50(2–3): 97–108.
Jaeger, J, Berns, S, Uzelac, S, Davis-Conway, S. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res. 2006; 145(1): 39–48.
Danner, M, Hummel, JM, Volz, F, etal. Integrating patients’ views into health technology assessment: analytical hierarchy process (AHP) as a method to elicit patient preferences. Int J Technol Assess Health Care. 2011; 27(4): 369–375.
Greer, TL, Kurian, BT, Trivedi, MH. Defining and measuring functional recovery from depression. CNS Drugs. 2010; 24(4): 267–284.
Douglas, KM, Porter, RJ. Longitudinal assessment of neuropsychological function in major depression. Aust N Z J Psychiatry. 2009; 43(12): 1105–1117.
Iverson, GL, Brooks, BL, Young, AH. Identifying neurocognitive impairment in depression using computerized testing. Appl Neuropsychol. 2009; 16(4): 254–261.
Gualtieri, CT, Johnson, LG, Benedict, KB. Neurocognition in depression: patients on and off medication versus healthy comparison subjects. J Neuropsychiatry Clin Neurosci. 2006; 18(2): 217–225.
Sullivan, MJL, Edgley, K, Dehoux, E. A survey of multiple sclerosis, part 1: perceived cognitive problems and compensatory strategy use. Canadian Journal of Rehabilitation. 1990; 4: 99–105.
Gershon, R, Rothrock, NE, Hanrahan, RT, etal. The development of a clinical outcomes survey research application: assessment center. Qual Life Res. 2010; 19(5): 677–685.
Lawrence, C, Roy, A, Harikrishnan, V, Yu, S, Dabbous, OH. The association between self-perceived cognitive difficulties and level of depression among employees with current depression. Podium presentation at the16th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). May 21–25, 2011 in Baltimore, MD, USA. Value Health. 2011;14(3 Suppl):A3.
Radloff, LS, Locke, BZ. Center for Epidemiologic Studies Depression Scale. In: Rush AJ, ed. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association; 2000: 523–525.
Demyttenaere, K, Ansseau, M, Constant, E, etal. Do general practitioners and psychiatrists agree about defining cure from depression? The DEsCRIBETM survey. BMC Psychiatry. 2011; 11: 169.
Zimmerman, M. Discordance between researchers and patients in defining remission from depression. J Clin Psychiatry. 2012; 73(9): 1262–1263.
Zimmerman, M, Martinez, JH, Attiullah, N, etal. Symptom differences between depressed outpatients who are in remission according to the Hamilton Depression Rating Scale who do and do not consider themselves to be in remission. J Affect Disord. 2012; 142(1–3): 77–81.
Benedict, RH, Munschauer, F, Linn, R, etal. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler. 2003; 9(1): 95–101.
Taylor, R. Relationships between cognitive test performance and everyday cognitive difficulties in multiple sclerosis. Br J Clin Psychol. 1990; 29(pt 2): 251–253.
Beatty, WW, Monson, N. Metamemory in multiple sclerosis. J Clin Exp Neuropsychol. 1991; 13(2): 309–327.
Lovera, J, Bagert, B, Smoot, KH, etal. Correlations of Perceived Deficits Questionnaire of Multiple Sclerosis Quality of Life Inventory with Beck Depression Inventory and neuropsychological tests. J Rehabil Res Dev. 2006; 43(1): 73–82.
Marrie, RA, Chelune, GJ, Miller, DM, Cohen, JA. Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis. Mult Scler. 2005; 11(1): 69–75.